InVivoMAb anti-mouse CD3epsilon F(ab)2 fragment

Sarikonda G, Sachithanantham S, Miller JF, et al. The Hsp60 peptide p277 enhances anti-CD3 mediated diabetes remission in non-obese diabetic mice. J Autoimmun. 2015,59:61-6. doi: 10.1016/j.jaut.2015.02.003

Kasahara K, Sasaki N, Yamashita T, et al. CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response. J Am Heart Assoc. 2014,3(2):e000719. doi: 10.1161/JAHA.113.000719

Shiheido H, Aoyama T, Takahashi H, et al. Novel CD3-specific antibody induces immunosuppression via impaired phosphorylation of LAT and PLCγ1 following T-cell stimulation. Eur J Immunol. 2014,44(6):1770-80. doi: 10.1002/eji.201344146

Kita T, Yamashita T, Sasaki N, et al. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. Cardiovasc Res. 2014,102(1):107-17. doi: 10.1093/cvr/cvu002

Grant CW, Moran-Paul CM, Duclos SK, et al. Testing agents for prevention or reversal of type 1 diabetes in rodents. PLoS One. 2013,8(8):e72989. doi: 10.1371/journal.pone.0072989